Akero therapeutics inc.

NA

AKRO


Executive/
Director

Price

  • Last Close
  • $ 28.23
    $ +0.16 0.57 %
    Jan 3, 2025
  • 52-Week High/Low
  • $52.25 - $11.38
  • YTD
  • 1.6%

  • Trading Volume
  • 18,858
  • Market Cap Full
  • $ 1.6B
  • Shares Outstanding
  • 55.7M
    Nov 3, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - - -5% 12.4% -32.5% -30.2% 8.2% 1.6%
Q2 - - - 4% 4% -14.5% -34.2% 22% -2.7% -
Q3 - - - 5.7% 8% -9.9% 260.3% 8.3% 0.5% -
Q4 - - - 14.3% -16.2% -4.7% 60.9% -49% -10.7% -
J F M A M J J A S O N D
2025 1.6% - - - - - - - - - - -
2024 -7.5% 24.9% -6.4% -17.9% -9.2% 24.2% 14.3% 0.5% - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%0%10%-17%157%-57%19%2%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - - - - -0.43 -0.74 -0.55
Q2 - - - 2.21 - -0.83 -0.77 -0.60
Q3 - - - 0.56 - -0.7 -0.92 -0.71
Q4 - - - - - -0.93 -0.44 -
A 0 0 0 -2.9 -2.5 -2.9 -2.9 -1.86

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2019 2020 2021 2022 2023
Mar - 28.6 34.8 35 47
Jun - 28.7 34.8 35 50.1
Sep 28.6 34.7 34.9 37.6 55.6
Dec 28.6 34.7 34.9 46.8 55.7

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 38.3 - 80 23 -0.2
Equity multiplier - - - - -